diagnostic histopathology
Recently Published Documents


TOTAL DOCUMENTS

86
(FIVE YEARS 3)

H-INDEX

14
(FIVE YEARS 0)

Der Pathologe ◽  
2021 ◽  
Author(s):  
Tim van der Lem ◽  
Merijn de Bakker ◽  
Gerhard Keuck ◽  
Michael K. Richardson

AbstractParaffin histology is one of the most important and commonly-used laboratory techniques in diagnostic histopathology. The discovery of paraffin embedding is often attributed to the pathologist Edwin Klebs. Klebs was following the lead of Stricker, who embedded embryos in a mixture of hot stearin and white beeswax. We show that Klebs experimented with paraffin wax for embedding tumour tissue. But he quickly rejected it as unsuitable because paraffin wax did not infiltrate the tissue. One of Klebs’ correspondents, embryologist Wilhelm His, Sr., learned of Klebs’ experiments and decided to try paraffin embedding. His dehydrated chicken embryos in alcohol, cleared them in lavender oil, and dripped hot paraffin wax onto them. This process allowed His to cut good sections. Here, we have replicated His’s paraffin embedding protocol in order to determine whether His had indeed made the landmark discovery of infiltration embedding with paraffin wax. We followed the protocol that he gives in his 1868 monograph on the early development of the chicken. The protocol described by His failed, in our hands, to yield sections of the quality that he illustrates in his monograph. Typically, the tissue disintegrated when sectioned due to poor infiltration of the wax. Usable sections could only be obtained if His’s protocol was modified by melting the embedded embryos in fresh paraffin wax. One explanation for our findings is that we failed to faithfully replicate His’s protocol. Another is that his protocol was incomplete. We suggest that His is likely to have discovered and perfected infiltration embedding with paraffin wax but did not publish a complete protocol.


2020 ◽  
Vol 155 (1) ◽  
pp. 148-149
Author(s):  
Syed A Hoda ◽  
Raza S Hoda

2018 ◽  
Vol 72 (3) ◽  
pp. 198-205 ◽  
Author(s):  
Bethany Jill Williams ◽  
David Bottoms ◽  
David Clark ◽  
Darren Treanor

Diagnostic histopathology departments are experiencing unprecedented economic and service pressures, and many institutions are now considering digital pathology as part of the solution. In this document, a follow on to our case for adoption report, we provide information and advice to help departments create their own clear, succinct, individualised business case for the clinical deployment of digital pathology.


Author(s):  
Giulio Rossi ◽  
Moira Ragazzi ◽  
Alberto Cavazza

2016 ◽  
Vol 23 (5) ◽  
pp. 517 ◽  
Author(s):  
P. Vashi ◽  
E. Abboud ◽  
C. Bier-Laning ◽  
D. Gupta

We present here a very rare clinical case of a 38-year-old man with Kaposiform hemangioendothelioma (khe) of the tongue who presented to our institution with a growth under the left side of the tongue with no pain or discomfort. There were no enlarged lymph nodes and no significant neurologic findings. Diagnostic histopathology confirmed the lesion to be khe. The tumour was removed surgically, and the surgical specimen confirmed the diagnosis. Follow-up at 3 months shows no clinical evidence of recurrence.


2015 ◽  
Vol 68 (10) ◽  
pp. 766-770 ◽  
Author(s):  
Kelly Elliott ◽  
Stephen McQuaid ◽  
Manuel Salto-Tellez ◽  
Perry Maxwell

Immunohistochemistry (IHC) is a widely available and highly utilised tool in diagnostic histopathology and is used to guide treatment options as well as provide prognostic information. IHC is subjected to qualitative and subjective assessment, which has been criticised for a lack of stringency, while PCR-based molecular diagnostic validations by comparison are regarded as very rigorous. It is essential that IHC tests are validated through evidence-based procedures. With the move to ISO15189 (2012), not just of the accuracy, specificity and reproducibility of each test need to be determined and managed, but also the degree of uncertainty and the delivery of such tests. The recent update to ISO 15189 (2012) states that it is appropriate to consider the potential uncertainty of measurement of the value obtained in the laboratory and how that may impact on prognostic or predictive thresholds. In order to highlight the problems surrounding IHC validity, we reviewed the measurement of Ki67and p53 in the literature. Both of these biomarkers have been incorporated into clinical care by pathology laboratories worldwide. The variation seen appears excessive even when measuring centrally stained slides from the same cases. We therefore propose in this paper to establish the basis on which IHC laboratories can bring the same level of robust validation seen in the molecular pathology laboratories and the principles applied to all routine IHC tests.


2015 ◽  
Vol 59 (1-2-3) ◽  
pp. 149-158 ◽  
Author(s):  
Faruk Skenderi ◽  
Semir Vranic ◽  
Ivan Damjanov

Sign in / Sign up

Export Citation Format

Share Document